首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

European Journal Of Pharmacology

European Journal Of Pharmacology杂志,由Elsevier出版,于1967年创刊,Weekly,出版语言English,ISSN:0014-2999,E-ISSN:1879-0712。

投稿咨询
European Journal Of Pharmacology
European Journal Of Pharmacology
European Journal Of Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.7
CiteScore
7.6
期刊收录
SCI、SCIE

European Journal Of Pharmacology(中文译名:《欧洲药理学杂志》),ISSN:0014-2999,EISSN:1879-0712,是Elsevier出版的国际性学术期刊,创刊于1967年,以Weekly形式稳定发行,2026年总发文量约1023篇。该刊采用混合开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.7,2025年期刊CiteScore为7.6,2025年期刊自引率约1.8%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。European Journal Of Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约1.4个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Japan、India、Iran、Brazil、Poland等为核心发文国家与地区;ZHENGZHOU UNIVERSITYCHINESE ACADEMY OF MEDICAL SCIENCES - PEKING UNION MEDICAL COLLEGE、CENTRAL SOUTH UNIVERSITY、SUN YAT SEN UNIVERSITY、TEHRAN UNIVERSITY OF MEDICAL SCIENCES、XI'AN JIAOTONG UNIVERSITY、CHINA PHARMACEUTICAL UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 52 / 356

85.5

学科:PHARMACOLOGY & PHARMACY SCIE Q1 28 / 356

92.28

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 54 / 352

84.8

学科:PHARMACOLOGY & PHARMACY SCIE Q1 35 / 353

90.23


中国学者近期发文

1
Multi-omics reveals rutin directly targets RUNX1 to disrupt the RUNX1/ TET2 complex and alleviate NAFLD via TLR4/NF-κB inhibitio

Author:He, Peikun; Luo, Zhenhui; Liu, Xiaoju; Fang, Fang; Yan, Qin; Liu, Baolan; Chen, Zhong; Yu, Zhijian; Hou, Tieying

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1023, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178862

2
IGF-1 attenuates high fat diet-elicited cardiomyopathy via arachidylcarnitine-dependent suppression of ferroptosis and mitochondrial dysfunctio

Author:Wang, Lin; Shen, Mingzhi; Abudureyimu, Miyesaier; Ye, Hua; Lin, Jie; Abdulkhaliq, Altaf A.; Reiter, Russel J.; Dong, Feng; Li, Guanmou; Dong, Maolong; Zou, Rongjun; Yuan, Ming; Lin, Ling; Ren, Jun

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1023, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178873

3
Cardiac-specific downregulation of KLF5 relieves myocardial ischemia/ reperfusion injury by restoring autophagic flu

Author:Mo, Huaqiang; Liu, Haiqiong; Ou, Wen; Zeng, Zhi; Xiao, Hua; Yang, Chaobo; Yan, Jing; Lu, Weizhe; Ling, Yuanna; Zhu, Yan; Song, Xudong; Chen, Aihua; Wang, Xianbao

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1022, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178832

4
Diosmetin improves myocardial ischemia/reperfusion injury via activation of the SIRT1/NRF2 axi

Author:Song, Yu; Cheng, Weiyi; Tang, Chuanbin; Sun, Anbang; Tuerxun, Yisilamujiang; Li, Yuanming; Du, Xinling; Huang, Xiaofan; Wu, Long

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1022, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178837

5
Regulation of OATP1B1 and OATP1B3 by HNF3α and/or c-Jun mediates rosuvastatin hepatic uptak

Author:Ren, Lan; Wang, Dong; He, Yun; Wu, Xiaolei; Zhu, Wenyu; Yin, Yijie; Lin, Yuqin; Yu, Xueping; Su, Zhijun; Wu, Yunli

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1022, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178853

6
Bidirectional interplay between methamphetamine and pulmonary infection: Impaired lung immunity and enhanced brain vulnerabilit

Author:Zhang, Wen; Wang, Xiaochen; Wu, Laiqiang; Liu, Xiaorui; Jiang, Qingchen; Chen, Yongyuan; Wang, Chen; Liao, Yuheng; Zhang, Yixin; Xue, Li; Wang, Rui; Chen, Teng; Chen, Yanjiong; Wang, Biao

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1021, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178807

7
Melatonin postconditioning attenuates myocardial ischemia/reperfusion injury by activating YAP to decrease DRP1-mediated mitochondrial fissio

Author:Tian, Tian; Hu, Bin; Li, Xin-Tao; Yang, Wen-He; Li, Xin-Yue; Cheng, Yi; Jin, Mu; Xue, Fu-Shan

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1021, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178827

8
Nstpbp5185, a novel benzimidazole derivative, suppresses PDGF signaling and reduces neointimal hyperplasia following vascular injur

Author:Hsu, Ming-Jen; Hsiao, Shih-Hsin; Lien, Jin-Cherng; Huang, Tur-Fu; Huang, Yu-Han; Huang, Shiu-Wen

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1021, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178824

9
Luteolin triggers autophagy-dependent ferroptosis via suppressing SLC40A1-related Fe2+efflux in hepatocellular carcinoma (HCC

Author:Li, Kunyang; Yu, Zhicheng; Zhou, Zhanyan; Wu, Yichen; Zhao, Yang; Zhang, Enxiang

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1021, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178809

10
Precision targeting of CD38 in immune thrombocytopenia: Mechanistic foundations and therapeutic implication

Author:Zhou, Xin; Liu, Yulu; Zhang, Peipei; Shan, Ningning

Journal: EUROPEAN JOURNAL OF PHARMACOLOGY. 2026; Vol. 1021, Issue , pp. -. DOI: 10.1016/j.ejphar.2026.178812


在线咨询

European Journal Of Pharmacology

国际简称:EUR J PHARMACOL参考译名:欧洲药理学杂志

年发文量:1023 CiteScore:7.6 是否预警:否 Gold OA文章占比:18.90% 研究类文章占比:97.65%

杂志社联系方式:ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

European Journal Of Pharmacology